Paper697347
Activity of 5-episisomicin compared with that of other aminoglycosides.
Fu KP and 1 other. Antimicrob Agents Chemother, 1978. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Activity of 5-episisomicin compared with that of other aminoglycosides. Papers, record 697347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/697347
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Gentamicins | Major topic |
| Sisomicin | Major topic |
| Aminoglycosides | |
| Bacillus | |
| Drug Synergism | |
| Enterobacteriaceae | |
| Gram-Negative Aerobic Bacteria | |
| Microbial Sensitivity Tests | |
| Staphylococcus aureus | |
| Streptococcus |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,829 | In vitro study of netilmicin compared with other aminoglycosides. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/10829 | PubMed |
| 2 | 416,011 | Uptake of (methyl-14C)-sisomicin and (methyl-14C)-gentamicin into bacterial cells. | J Antibiot (Tokyo) | 1978 | https://conductscience.org/library/papers/416011 | PubMed |
| 3 | 626,490 | Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/626490 | PubMed |
| 4 | 791,104 | In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/791104 | PubMed |
| 5 | 787,451 | Tobramycin: an overview. | J Infect Dis | 1976 | https://conductscience.org/library/papers/787451 | PubMed |
| 6 | 4,581,231 | Mechanisms of antibiotic resistance in bacteria. | Annu Rev Biochem | 1973 | https://conductscience.org/library/papers/4581231 | PubMed |
| 7 | 4,468,277 | Mutamicins; biosynthetically created new sisomicin analogues. | J Antibiot (Tokyo) | 1974 | https://conductscience.org/library/papers/4468277 | PubMed |
| 8 | 166,284 | Aminoglycoside-modifying enzymes. | Methods Enzymol | 1975 | https://conductscience.org/library/papers/166284 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,967,296 | 5-epi-Sisomicin and 5-epi-Gentamicin B: substrates for aminoglycoside-modifying enzymes that retain activity against aminoglycoside-resistant bacteria. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6967296 | PubMed |
| 6,775,590 | UK31214, a new aminoglycoside and derivative of kanamycin B. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6775590 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/697347
GET https://conductscience.org/api/papers/v1/697347/authors